Health News

• GSK's ViiV seeks marketing license for baby-friendly HIV...

  13 Dec 2019 10:35

  British drugmaker GSK applied on Friday for a license to market its HIV drug dolutegravir in a formulation designed to be easier for babies and children who are living with the virus to swallow

  Source: Reuters - U.K. Health

• Roche's Tecentriq cocktail scores trial success in...

  A late-stage clinical trial has shown therapy combining Roche's...

  Reuters - U.K. Health - 13 Dec 2019 08:05

• Social media use linked to teen disordered eating...

  (Reuters Health) - Adolescents who are active on social media may be...

  Reuters - U.K. Health - 13 Dec 2019 22:10

• FDA panel votes unanimously in favor of Horizon's...

  Independent advisers to the U.S. Food and Drug Administration on...

  Reuters - U.K. Health - 13 Dec 2019 20:51

• FDA says Amarin can market fish-oil derived therapy for...

  Reuters - U.K. Health - 13 Dec 2019 22:05

• Ebola spreads in Congo after militants attack treatment...

  Reuters - U.K. Health - 13 Dec 2019 13:12

• Two-century trend of Army suicide decrease during war...

  Reuters - U.K. Health - 13 Dec 2019 20:44

• Santa Anita introduces new technology to aid horses

  Reuters - U.K. Health - 13 Dec 2019 21:13

• U.S. FDA approves Tandem's predictive insulin pump...

  Reuters - U.K. Health - 13 Dec 2019 17:11

• Gender bias roughly similar among scientists in Spain...

  Reuters - U.K. Health - 13 Dec 2019 16:58